<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//FR">
<HTML>
<HEAD>
 <LINK HRef="../CSS/ggrcm.css" Rel="stylesheet" Type="text/css">
 <META name="description" content="Antithyro&iuml;diens">
 <META name="keywords" content="Antithyro&iuml;diens, R&eacute;pertoire Comment&eacute; des M&eacute;dicaments (C.B.I.P. aslb)">
 <META name="GGR_Kruimelpad" content=" Systeme hormonal / Pathologie de la thyroide / ">
 <META name="GGR_HyrTree" content="5.2.3.">
 <cfinclude template="/include/SPC.cfm"/>
  <script SRC="/JS/jquery-1.3.2.min.js"></script>
  <script SRC="/JS/jquery.qtip-1.0.0-rc3.min.js"></script>
  <!---script SRC="/JS/qTip_FR.js"></script--->
 <TITLE>Antithyro&iuml;diens</TITLE>
</HEAD>

<BODY bgcolor="#FFFFFF" LeftMargin="0" RightMargin="0" TopMargin="0" BottomMargin="0" MarginWidth="0" MarginHeight="0" id="bodykw">
 <A Name="TopOfPage"></A>

  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%"><A HRef="../HeaderTxt/LeCBIP.htm">Le C.B.I.P.</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/NousContacter.htm">Nous contacter</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/Liens.htm">Sites Int&eacute;ressantes</A></TD>
   </TR> 
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%" Class="footer">Bon &agrave; savoir</TD>
    <TD Width="30%"><A HRef="../Index.htm"><B>Le R&eacute;pertoire</B></A></TD>
    <TD Width="30%" Class="footer">Folia</TD>
   </TR> 
   <TR> 
    <TD ColSpan="4"><HR></TD>
   </TR> 
  </TABLE> 

 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
  <TR>
   <TD vAlign="top" Width="260">
  <!--- begin van linker "tafel" met TOC --->
    <TABLE Width="260" Border="0" CellPadding="0" CellSpacing="0" BgColor="#DEFFD6" style="border: solid #000000 1px">
     <TR>
      <TD ColSpan="3" Align="center" BgColor="#008000">
       <FONT Face="Arial" Size="2" Color="#FFFFFF"><STRONG>Table des mati&egrave;res</STRONG></FONT></TD>
     </TR>
     <TR>
      <TD Width="3">&nbsp;</TD>
      <TD Width="256">
       <TABLE Width="100%" Border="0" CellPadding="2" CellSpacing="0">
        <TR>
         <TD  Colspan="2"><IMG SRC="../Images/Pixel_Transp.gif" Alt="" Width="1" Height="5" Border="0"></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">&nbsp;</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="/GGR/Index_Intro.cfm" Class="toc">Introduction</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">1.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_A.htm" Class="toc">Syst&egrave;me cardio-vasculaire</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">2.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_B.htm" Class="toc">Sang et coagulation</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">3.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_C.htm" Class="toc">Syst&egrave;me gastro-intestinal</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">4.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_D.htm" Class="toc">Syst&egrave;me respiratoire</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.</TD>
         <TD vAlign="top" Class="toc"><A HRef="../MPG/MPG_E.htm" Class="toc">Syst&egrave;me hormonal</A></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.2.</TD>
         <TD vAlign="top" Class="toc"><A HRef="../MPG/MPG_EB.htm" Class="toc">&nbsp;Pathologie de la thyro&iuml;de</A></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr" BgColor="#FFFF99">5.2.3.</TD>
         <TD vAlign="top" Class="toc" BgColor="#FFFF99">&nbsp;&nbsp;Antithyro&iuml;diens</TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.2.3.1.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_EBCA" Class="toc">&nbsp;&nbsp;&nbsp;Propylthiouracile</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.2.3.2.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_EBCB" Class="toc">&nbsp;&nbsp;&nbsp;Thiamazol</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">6.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_F.htm" Class="toc">Gyn&eacute;co-obst&eacute;trique</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">7.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_G.htm" Class="toc">Syst&egrave;me urog&eacute;nital</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">8.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_H.htm" Class="toc">Douleur et fi&egrave;vre</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">9.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_I.htm" Class="toc">Pathologies ost&eacute;o-articulaires</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">10.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_J.htm" Class="toc">Syst&egrave;me nerveux</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">11.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_K.htm" Class="toc">Infections</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">12.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_L.htm" Class="toc">Immunit&eacute;</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">13.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_M.htm" Class="toc">M&eacute;dicaments antitumoraux</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">14.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_N.htm" Class="toc">Min&eacute;raux, vitamines et toniques</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">15.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_O.htm" Class="toc">Dermatologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">16.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_P.htm" Class="toc">Ophtalmologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">17.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_Q.htm" Class="toc">Oto-Rhino-Laryngologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">18.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_R.htm" Class="toc">Anesth&eacute;sie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">19.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_S.htm" Class="toc">Agents de diagnostic</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">20.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_T.htm" Class="toc">M&eacute;dicaments divers</A><BR>
         </TD>
        </TR>
       </TABLE>
       <BR>
      </TD>
     </TR>
    </TABLE>
    <DIV class="normal_font">&nbsp; <strong>Nom de sp&eacute;cialit&eacute;:</strong></DIV>
    <table border="0" cellspacing="2" cellpadding="1" align="center">
     <tr>
      <td align=center class="letter"><A href="../Merk/MP_A.htm" class="letterlink">&nbsp;A&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_B.htm" class="letterlink">&nbsp;B&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_C.htm" class="letterlink">&nbsp;C&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_D.htm" class="letterlink">&nbsp;D&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_E.htm" class="letterlink">&nbsp;E&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_F.htm" class="letterlink">&nbsp;F&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_G.htm" class="letterlink">&nbsp;G&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_H.htm" class="letterlink">&nbsp;H&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_I.htm" class="letterlink">&nbsp;I&nbsp;</A></td>
     </tr><tr>
      <td align=center class="letter"><A href="../Merk/MP_J.htm" class="letterlink">&nbsp;J&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_K.htm" class="letterlink">&nbsp;K&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_L.htm" class="letterlink">&nbsp;L&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_M.htm" class="letterlink">&nbsp;M&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_N.htm" class="letterlink">&nbsp;N&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_O.htm" class="letterlink">&nbsp;O&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_P.htm" class="letterlink">&nbsp;P&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Q.htm" class="letterlink">&nbsp;Q&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_R.htm" class="letterlink">&nbsp;R&nbsp;</A></td>
     </tr><tr>
      <td align=center class="letter"><A href="../Merk/MP_S.htm" class="letterlink">&nbsp;S&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_T.htm" class="letterlink">&nbsp;T&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_U.htm" class="letterlink">&nbsp;U&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_V.htm" class="letterlink">&nbsp;V&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_W.htm" class="letterlink">&nbsp;W&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_X.htm" class="letterlink">&nbsp;X&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Y.htm" class="letterlink">&nbsp;Y&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Z.htm" class="letterlink">&nbsp;Z&nbsp;</A></td>
     </tr>
    </table>
    <DIV class="normal_font">&nbsp; <strong>Principe actif</strong></DIV>
    <table border="0" cellspacing="2" cellpadding="1" align="center">
     <TR>
      <TD Class="letter" Align="center"><A HRef="../Stof/IN_A.htm" Class="letterlink">&nbsp;A&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_B.htm" Class="letterlink">&nbsp;B&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_C.htm" Class="letterlink">&nbsp;C&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_D.htm" Class="letterlink">&nbsp;D&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_E.htm" Class="letterlink">&nbsp;E&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_F.htm" Class="letterlink">&nbsp;F&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_G.htm" Class="letterlink">&nbsp;G&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_H.htm" Class="letterlink">&nbsp;H&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_I.htm" Class="letterlink">&nbsp;I&nbsp;</A></TD>
     </TR><TR>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_J.htm" Class="letterlink">&nbsp;J&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_K.htm" Class="letterlink">&nbsp;K&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_L.htm" Class="letterlink">&nbsp;L&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_M.htm" Class="letterlink">&nbsp;M&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_N.htm" Class="letterlink">&nbsp;N&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_O.htm" Class="letterlink">&nbsp;O&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_P.htm" Class="letterlink">&nbsp;P&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Q.htm" Class="letterlink">&nbsp;Q&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_R.htm" Class="letterlink">&nbsp;R&nbsp;</A></TD>
     </TR><TR>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_S.htm" Class="letterlink">&nbsp;S&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_T.htm" Class="letterlink">&nbsp;T&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_U.htm" Class="letterlink">&nbsp;U&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_V.htm" Class="letterlink">&nbsp;V&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_W.htm" Class="letterlink">&nbsp;W&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_X.htm" Class="letterlink">&nbsp;X&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Y.htm" Class="letterlink">&nbsp;Y&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Z.htm" Class="letterlink">&nbsp;Z&nbsp;</A></TD>
     </TR>
    </TABLE>

   </TD>
<!--- einde van linker "tafel" met TOC --->

<!--- tussen kolommetje --->
   <TD Width="20"></TD>

<!--- begin van rechter "tafel" met ThGrp en M info --->
   <TD vAlign="top">
   
    <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
     <TR> 
      <TD RowSpan="2" Width="10"></TD>
      <TD Width="70%"><STRONG><FONT Face="Arial" Size="2">R&eacute;pertoire Comment&eacute; des M&eacute;dicaments</FONT></STRONG></TD> 
      <TD Width="29%" Align="Right" Class= "Datum">&nbsp;
       Avril 2015&nbsp;&nbsp;
      </TD>
      <TD Rowspan="2" Width="10"></TD>
     </TR>
     <TR>
      <TD Colspan="2"><HR Width="100%" Size="1" Color="green" NOSHADE></TD>
     </TR>
    </TABLE>

    <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
     <TR>
      <TD Width="10"><A Name="TiCv00459"></A>&nbsp;</TD>
      <TD><H2>Antithyro&iuml;diens</H2></TD>
      <TD Width="10">&nbsp;</TD>
     </TR>
     <TR>
      <TD Width="10">&nbsp;</TD>
      <TD vAlign="top">
<!---    Start van de HYR->INTRO informatie blok--->
<A Name="Topic_A"><B>Positionnement</B></A><UL Class="Text"> <LI Class="Text">Les thioamides (syn. thiour&eacute;es) repr&eacute;sentent le traitement de base de l'hyperthyro&iuml;die dans la maladie de Graves-Basedow.</LI> <LI Class="Text">Les antithyro&iuml;diens n'ont qu'une utilit&eacute; limit&eacute;e en cas d'ad&eacute;nome toxique ou de goitre multinodulaire toxique. Elles n&rsquo;ont pas de place dans la thyro&iuml;dite.</LI> <LI Class="Text">Un &beta;-bloquant, tel le propranolol, peut &ecirc;tre indiqu&eacute; pour att&eacute;nuer les sympt&ocirc;mes d'hyperthyro&iuml;die et &eacute;viter les probl&egrave;mes cardiaques; le propranolol inhibe en outre la conversion de T<SUB>4</SUB> en T<SUB>3</SUB>.</LI> <LI Class="Text">Les antithyro&iuml;diens sont utilis&eacute;s en pr&eacute;vention de l'hyperthyro&iuml;die en cas d'administration de produits de contraste iod&eacute;s chez certains patients qui ont d&eacute;j&agrave; une production accrue d'hormones thyro&iuml;diennes (indication non reprise dans le R&eacute;sum&eacute; des Caract&eacute;ristiques du Produit ou RCP).</LI></UL>
<A Name="Topic_B"><B>Indications</B></A><UL Class="Text"> <LI Class="Text">Hyperthyro&iuml;die due &agrave; la maladie de Graves-Basedow, surtout chez les patients de moins de 40 ans.</LI> <LI Class="Text">Normalisation de la fonction thyro&iuml;dienne avant une thyro&iuml;dectomie ou avant l'administration d'iode radioactif pour hyperthyro&iuml;die.</LI></UL>
<A Name="Topic_C"><B>Contre-indications principales</B></A><UL Class="Text"> <LI Class="Text">Insuffisance h&eacute;patique s&eacute;v&egrave;re.</LI></UL>
<A Name="Topic_D"><B>Effets ind&eacute;sirables principaux</B></A><UL Class="Text"> <LI Class="Text">Hypothyro&iuml;die: r&eacute;versible &agrave; l'arr&ecirc;t du traitement.</LI> <LI Class="Text">Goitre.</LI> <LI Class="Text">Rash, perte de cheveux et troubles gastro-intestinaux: fr&eacute;quent.</LI> <LI Class="Text">Atteinte h&eacute;patique: rare; risque plus &eacute;lev&eacute; avec le propylthiouracile.</LI> <LI Class="Text">Arthralgies: rare.</LI> <LI Class="Text">Vasculite: rare.</LI> <LI Class="Text"><B>Agranulocytose chez environ 0,5% des patients, le plus souvent au cours des trois premiers mois de traitement.</B> Cet effet est r&eacute;versible mais grave (<I>voir la rubrique "Pr&eacute;cautions particuli&egrave;res").</I></LI></UL>
<A Name="Topic_T"><B>Grossesse et allaitement</B></A><UL Class="Text"> <LI Class="Text">L'hyperthyro&iuml;die repr&eacute;sente une menace s&eacute;rieuse pour l'&eacute;volution normale de la grossesse.</LI> <LI Class="Text">Avec le propylthiouracile et le thiamazol, des troubles thyro&iuml;diens (hypothyro&iuml;die, goitre) peuvent survenir chez le nouveau-n&eacute; (rare).</LI> <LI Class="Text"><B>Thiamazol: suspicion d'une t&eacute;ratog&eacute;nicit&eacute;; le thiamazol est d&egrave;s lors d&eacute;conseill&eacute; pendant le premier trimestre de la grossesse.</B></LI> <LI Class="Text"><B>Pendant la grossesse, un sch&eacute;ma th&eacute;rapeutique &agrave; base d&rsquo;un antithyro&iuml;dien et de l&eacute;vothyroxine est formellement contre-indiqu&eacute;.</B></LI></UL>
<A Name="Topic_E"><B>Interactions principales</B></A><UL Class="Text"> <LI Class="Text">Diminution de l'effet des antagonistes de la vitamine K cons&eacute;cutive au ralentissement de la m&eacute;tabolisation des facteurs de coagulation.</LI></UL>
<A Name="Topic_F"><B>Pr&eacute;cautions principales</B></A><UL Class="Text"> <LI Class="Text">Etant donn&eacute; le risque d'agranulocytose, il faut avertir le patient qu'il doit signaler imm&eacute;diatement tout &eacute;pisode f&eacute;brile ou infectieux. Un contr&ocirc;le h&eacute;matologique r&eacute;gulier est n&eacute;cessaire.</LI> <LI Class="Text">Etant donn&eacute; le risque d'hypothyro&iuml;die iatrog&egrave;ne, il convient parfois d'associer des hormones thyro&iuml;diennes.</LI> <LI Class="Text">Propylthiouracile: suivre les transaminases.</LI></UL>
<A Name="Topic_V"><B>Posologie</B></A><UL Class="Text"> <LI Class="Text">La posologie ci-dessous est celle du d&eacute;but du traitement. L'hyperthyro&iuml;die s&eacute;v&egrave;re peut n&eacute;cessiter une posologie plus &eacute;lev&eacute;e.</LI> <LI Class="Text">Des doses &eacute;lev&eacute;es doivent &ecirc;tre donn&eacute;es aussi longtemps que les signes d'hyperthyro&iuml;die persistent et que les concentrations plasmatiques d'hormones thyro&iuml;diennes sont &eacute;lev&eacute;s.</LI> <LI Class="Text">Dans la maladie de Graves-Basedow, la dose est progressivement r&eacute;duite en fonction des param&egrave;tres thyro&iuml;diens jusqu'&agrave; une dose d'entretien qui est habituellement poursuivie pendant 1 &agrave; 2 ans; apr&egrave;s 3 &agrave; 6 semaines, la dose de d&eacute;part peut g&eacute;n&eacute;ralement &ecirc;tre fortement r&eacute;duite.</LI></UL>
<!---    Start van de MP blok(ken)--->
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv01762"></A><A Name="MPG_EBCA"><B>Propylthiouracile</B></A></P>
     <TABLE Class="MPGposol_MPG" Width="100%">
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG"><B>Posologie</B></TD>
      </TR>
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG">300 &agrave; 600 mg p.j. en 3 prises, ensuite diminuer progressivement<BR></TD>
      </TR>
     </TABLE>

       <BR>
       <A Name="MP_01311"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Propylthiouracile
         <FONT Class="IR_MPG">(Takeda)</FONT></TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[propylthiouracile]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">compr.</TD>
        </TR>
        <TR vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE022373&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE022373&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_EBCA.htm#Vos_02245" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 0072298<BR><B>CTI</B>: 022373<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">60 x&nbsp;50mg </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right">&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 8,65</TD>
        </TR>
       </TABLE>
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv01763"></A><A Name="MPG_EBCB"><B>Thiamazol</B></A></P>
     <TABLE Class="MPGposol_MPG" Width="100%">
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG"><B>Posologie</B></TD>
      </TR>
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG">30 mg p.j. en 1 &agrave; 3 prises, ensuite diminuer progressivement<BR></TD>
      </TR>
     </TABLE>

       <BR>
       <A Name="MP_01312"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Strumazol
         <FONT Class="IR_MPG">(Takeda)</FONT></TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[thiamazol]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">compr. (s&eacute;c.)</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE086371&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE086371&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_EBCB.htm#Vos_02529" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 0083725<BR><B>CTI</B>: 086371<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">100 x&nbsp;10mg </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><IMG vAlign="Top" Width="10" Height="16" SRC="../Images/B.gif"><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 9,26</TD>
        </TR>
       </TABLE>
<!---
       <P Class="datum">
       <A Href="#TopOfPage">
        <IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A>&nbsp;</P>
--->
      </TD>
      <TD Width="10">&nbsp;</TD>
     </TR>
    </TABLE>
    <BR>
 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
  <TR>
   <TD Align="center">
    <HR WIDTH="90%" SIZE="1" COLOR="#008000" NOSHADE>
    <SPAN Class="footer">
 Centre Belge d 'Information Pharmacoth&eacute;rapeutique (C.B.I.P. asbl) <BR>
 c/o Heymans Instituut, De Pintelaan 185, 9000 Gent<BR>
 </SPAN>
 <A HRef="" Target="_top" Class="footer_link"><font color="#0000FF"></font></A> -
 <A HRef="mailto:redaction@cbip.be" Class="footer_link"><font color="#0000FF">redaction@cbip.be</font></A>
 - <A HRef="../Headertxt/Avertissement.htm" target="_blank" class="footer_link"><FONT Color="#0000FF">Avertissement / Disclaimer</FONT></A>
   </TD>
  </TR>
 </TABLE>
<!--- einde van de rechter "tafel" met MP info--->

   </TD>
  </TR>
 </TABLE>
<script language="JavaScript" type="text/javascript" SRC="../JS/wz_tooltip.js"></script>
</BODY>
</HTML>
<CFINCLUDE template="/search/incHighLightScriptJQuery.cfm">
